- 1、本文档共4页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
我院415例患者注射用脑蛋白水解物应用分析
*
殷秀惠 ,王 丽,孔祥俊,李静蓉,台琪瑞,陈 勇(玉溪市人民医院,云南玉溪 653100)
中图分类号 R74;R917 文献标志码 A 文章编号 1001-0408(2015)05-0589-04
DOI 10.6039/j.issn.1001-0408.2015.05.05
摘 要 目的:为临床合理使用注射用脑蛋白水解物提供参考。方法:调取我院2014年1-4月使用注射用脑蛋白水解物部份病
历,参照药品说明书、专著、临床诊疗指南,就其应用适应证、用法用量、溶剂选用、配置浓度、用药时间、用药禁忌等内容进行回顾性
统计、分析,讨论其用药合理性。结果:共收集415例患者信息,有112例病例存在用药不合理情况,占26.99%。其中无指征用药47
例,占11.33%;溶剂选择不合理72例,占17.35%;配置浓度不当2例,占0.48%;存在用药禁忌1例,占0.24%;疗程不当17例,占
4.10%。病例中同时存在两项不合理的有27例,占6.5%。结论:临床应用注射用脑蛋白水解物存在不合理现象,提示医务人员需
充分掌握该药适应证,严格按照药品说明书规范使用,建立可持续改进的辅助用药管理体系,以促进临床安全、合理、经济用药。
关键词 注射用脑蛋白水解物;神经营养;辅助用药;合理用药
Analysis of the Utilization of Cerebroprotein Hydrolysate for Injection in 415Cases of Our Hospital
YIN Xiu-hui ,WANG Li ,KONG Xiang-jun ,LI Jing-rong ,TAI Qi-rui ,CHEN Yong (Yuxi Municipal People ’s Hospi-
tal ,Yunnan Yuxi 653100,China )
ABSTRACT OBJECTIVE :To provide reference for ratioral use of cerobroprotein hydrolysate for injection in the clinic. METH-
ODS :The cases of Cerebroprotein hydrolysate for injection were collected from our hospital during Jan.-Apr. 2014,and then analyzed
retrospectively in terms of indications ,usage and dosage ,the selection of solvent ,the concentration of configuration ,drug use time ,
taboo and so on according to drug package inserts ,treatise and clinical treatment guide. The rationality of drug use was discussed. RE-
SULTS :Among 415cases ,there were 112cases of irrational drug use ,accounting for 26.99%. There were 47cases of nonindicated
use of drugs (11.33%),72cases of irrational solvent selection (17.35%),2cases of improper configuration concentration (0.48%),
1case of taboo (0.24%),17cases of improper treatment period (4.10%). Among them ,2items of irrational data existed in 27cas-
es ,accounting for 6.5%. CONCLUSIONS :The clinical application of Cerebroprotein hydrolysate for injection existed unreasonable
phenomenon ,thus it ’s remind the medical staff should know the drug indica
文档评论(0)